Since Aβ-induced Tau-pathology is situated at the effective beginning of AD, i.e. the conversion from preclinical stages to MCI and subsequently to AD, it is considered as a key-pathogenetic mechanism. This evidence concerns the gene MAPT and Alzheimer disease.